
Curaleaf chairman on the arena enlargement of cannabis availability
Curaleaf executive chairman Boris Jordan joins “Negate on the Motorway” to focus on the firm’s enlargement into Europe. For entry to are living and consuming video from CNBC subscribe to…

Jim Cramer on investing within the cannabis and gambling sectors
CNBC’s Jim Cramer and David Faber mark in on the cannabis and gambling sectors.

Inexperienced Thumb to sell clinical cannabis at Florida fuel stations
Ben Kovler, Inexperienced Thumb Industries CEO, joins ‘Dispute on the Road’ to debate a brand novel partnership with CircleK fuel stations in Florida, the ability and measurement of Florida’s cannabis…

ETF Highlight: Aurora cannabis hit by pandemic-connected restrictions
CNBC’s Morgan Brennan takes a glance at cannabis-focused ETFs and the dip in Aurora shares. For salvage entry to to stay and abnormal video from CNBC subscribe to CNBC PRO:…

Cannabis company Parallel CEO on going public via SPAC
Beau Wrigley, Parallel chairman and CEO, on taking his cannabis company public via a SPAC merger with Ceres Acquisition Corporation and the future of the cannabis industry. For access to…

Jim Cramer explains why many cannabis stocks were lower Wednesday morning
CNBC’s Jim Cramer explains how the election results are impacting some of the big cannabis stocks. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Oregon…

Here’s how Joe Biden’s election win could affect the cannabis industry
Emily Paxhia, managing partner at Poseidon Asset Management, joins “Squawk on the Street” to discuss her outlook for the cannabis industry. For access to live and exclusive video from CNBC…

Curaleaf executive chairman on the future of the cannabis industry
Boris Jordan, Curaleaf executive chairman, joins ‘Squawk on the Street’ to discuss the future of the cannabis industry and where he sees the opportunity in market. For access to live…

Jim Cramer on cannabis companies Aphria and Tilray merging
Cannabis companies Aphria and Tilray will merge to create the largest global cannabis company. CNBC’s Jim Cramer and David Faber discuss. Subscribe to CNBC PRO for access to investor and…